pGST2-GST-TEV-OPTN S177D S473D
(Plasmid
#187827)
-
PurposePlasmid for the expression and purification of GST-TEV-OPTN S177D S473D. Internal Ref: SMC1588
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 187827 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGST2
-
Backbone manufacturerJames Hurley Lab
- Backbone size w/o insert (bp) 4905
- Total vector size (bp) 6694
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameOPTN
-
Alt nameGLC1E
-
SpeciesH. sapiens (human)
-
MutationS177D S473D
-
GenBank ID10133 NM_021980
-
Entrez GeneOPTN (a.k.a. ALS12, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP)
-
Tag
/ Fusion Protein
- GST-TEV (N terminal on insert)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer CATGTCCCCTATACTAGGTTATTGGAAAAT
- 3′ sequencing primer TTAaatgatgcaatccatcacgtgaatctg (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byThe lab of James Hurley: Plasmid #171425
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pGST2-GST-TEV-OPTN S177D S473D was a gift from Sascha Martens (Addgene plasmid # 187827 ; http://n2t.net/addgene:187827 ; RRID:Addgene_187827) -
For your References section:
Unconventional initiation of PINK1/Parkin mitophagy by Optineurin. Nguyen TN, Sawa-Makarska J, Khuu G, Lam WK, Adriaenssens E, Fracchiolla D, Shoebridge S, Bernklau D, Padman BS, Skulsuppaisarn M, Lindblom RSJ, Martens S, Lazarou M. Mol Cell. 2023 May 18;83(10):1693-1709.e9. doi: 10.1016/j.molcel.2023.04.021. 10.1016/j.molcel.2023.04.021 PubMed 37207627